Natural products are excellent sources of lead compounds in the search for new medicaments for the treatment of diseases. The largest present underexplored source of such materials lies in tropical and subtropical regions of the world. In these areas, a long tradition of ethnobotanical medicine often exists and offers a rich and relatively untapped source for the discovery of new drugs from natural products. Vietnam, a tropical Southeast Asian country, also has a long history of traditional medicine systems. 1) However, systematic exploitation of these natural resources for their human health benefits has not been carried out to a significant degree.
assayed spectrophotometrically under aerobic conditions, based on the procedure reported by Noro et al., 8) with modification by using 96-well plates. The assay mixture consisting of 50 ml of test solution, 35 ml of 70 mM phosphate buffer (pHϭ7.5), and 30 ml of enzyme solution (0.01 units/ml in 70 mM phosphate buffer, pHϭ7.5) was prepared immediately before use. After preincubation at 25°C for 15 min, the reaction was initiated by the addition of 60 ml of substrate solution (150 mM xanthine in the same buffer). The assay mixture was incubated at 25°C for 30 min. The reaction was stopped by adding 25 ml of 1 N HCl, and the absorbance at 290 nm was measured with a Perkin-Elmer HTS-7000 Bio Assay Reader (Norwalk, CT, U.S.A.). A blank was prepared in the same way, but the enzyme solution was added to the assay mixture after adding 1 N HCl. One unit of XO is defined as the amount of enzyme required to produce 1 mmol of uric acid/min at 25°C.
XO inhibitory activity was expressed as the percentage inhibition of XO in the above assay system, calculated as (1ϪB/A)ϫ100, where A and B are the activities of the enzyme without and with test material. IC 50 values were calculated from the mean values of data from four determinations.
The crude extracts were dissolved initially in DMSO followed by dilution with the buffer; the final concentration of DMSO was less than 0.25%. Allopurinol, a known inhibitor of XO, was used as a positive control.
Extraction and Isolation of the Active Compounds from the Flower of Chrysanthemum sinense Dried flower (10.7 g) of C. sinense was extracted with MeOH (300 ml, ϫ3) under reflux for 2 h, to yield a MeOH extract (1.4 g; IC 50 value, 5.06 mg/ml). The MeOH extract (650 mg) was chromatographed on silica gel with a MeOH-CHCl 3 solvent system to give six fractions: fr. 1 (107 mg; IC 50 , Ͼ100 mg/ml), fr. 2 (152 mg; IC 50 , Ͼ100 mg/ml), fr. 3 (49.6 mg; IC 50 , 1.3 mg/ml), fr. 4 (49.6 mg; IC 50 , 6.3 mg/ml), fr. 5 (49.6 mg; IC 50 , 11.9 mg/ml), fr. 6 (49.6 mg; IC 50 , 78.8 mg/ml). Fraction 3 was separated by reversed-phase preparative TLC with CH 3 CN-MeOH-H 2 O (1 : 1 : 2) to give caffeic acid 2) (1, 3.6 mg) and luteolin 9) (2, 4.9 mg). Fraction 4 was separated by reversed-phase preparative TLC with CH 3 CN-MeOH-H 2 O (1 : 1 : 2) to give eriodictyol 10) (3, 1.7 mg), while fraction 5 was subjected to reversed-phase preparative TLC with acetone-CH 3 CN-H 2 O (2 : 2 : 7) to give 1,5-di-O-caffeoylquinic acid 11) (4, 6.4 mg). Their structures were identified by spectral analysis and comparison of their data with those in the literature.
RESULTS AND DISCUSSION
Xanthine oxidase (XO) is an enzyme that has been investigated for decades. Natural XO inhibitors were reported from a variety of plants used in traditional herbal medicines for the treatment of gout and rheumatism in China, 12) Australia, 13) North America, 3) Chile, 14) Paraguay, 15) and Panama. 16) Vietnam, a country possessing a long history of traditional medicine system, also has a number of medicinal plants used for gout and rheumatism, but no systematic investigations have been reported until now. In the present study, 96 plants from Vietnam were selected based on their ethnomedical use for the treatment of rheumatism, arthritis, and gout by the natives of this region (Table 1) and were successively extracted with MeOH, MeOH-H 2 O (1 : 1) and H 2 O to give 288 crude extracts. All of these extracts were tested for their XO inhibitory activity to identify potential anti-gout agents. The assay was carried out at four different concentrations of extract ranging from 10-100 mg/ml (Table 2) .
Of the extracts assayed, 188 extracts (65.3%) demonstrated XO inhibitory activity at 100 mg/ml, among which 46 (24.5%) showed an inhibition rate greater than 50%. Altogether, 168 extracts (58.3%) were found to be active at a concentration of 50 mg/ml, among which 21 (12.5%) showed inhibition of more than 50%. At 25 mg/ml, 146 extracts (50.7%) were active, and eight (5.5%) showed an inhibition of over 50%. Of the extracts assayed, 126 (43.8%) displayed activity at 10 mg/ml, including two (1.6%) of over 50% inhibition. In total, 49 [ 17) this is the first report on their XO inhibitory activity.
The aerial part of A. vulgaris is widely used for the treatment of rheumatism and fever in Vietnam. The phytochemical studies on this plant species reported that it contains a number of flavonoids (e.g., apigenin, eriodictyol, kaempferol, luteolin) as the major constituents, together with monoterpenes, sesquiterpene lactones, and other compounds. [18] [19] [20] Flavonoids are well known antioxidants and attract a tremendous amount of interest among researchers as possible therapeutic agents for diseases mediated by free radicals. Flavonoids are also effective inhibitors of several enzymes including XO, cyclooxygenase, and lipooxigenase. [21] [22] [23] Thus, the putative therapeutic effects of A. vulgaris and its XO inhibitory activity are ascribed to its flavonoid constituents. Another Asteraceae plant, B. balsamifera, is also reported to contain a number of flavonoids inhibiting XO. [21] [22] [23] [24] [25] It is interesting to note that the wood of C. sappan possesses various biological activities such as antioxidative, antiinflammatory, hepatoprotective, cytotoxic, and hypoglycemic activity. Among the activities, the antioxidative activity is the most widely studied, and was attributed to the presence of phenolic compounds such as brazilin and flavanoids. 26, 27) Two phenolic compounds isolated from C. sappan, 1Ј,4Ј-dihydro-spiro[benzofuran-3(2H),3Ј-[3H-2]benzopyran]-1Ј,6Ј,6Ј,7Ј-tetrol and 3-[[4,5-dihydroxy-2-(hydroxymethyl)-phenyl]methyl]-2,3-dihydro-3,6-benzofurandiol, were reported to inhibit XO. 28) Thus, the phenolic constituents may play an essential role in the inhibition of XO by C. sappan. Although all three extracts of T. scandens showed XO inhibitory activity, there are no scientific reports on their chemical constituents and biological activity. However, the presence of flavonoids such as derivatives of quercetin, kaempferol, apigenin, luteolin, and myricetin, have been reported together with the antioxidative and hepatoprotective activities in other Tetracera species. [29] [30] [31] [32] Thus, the XO inhibitory activity of T. scandens also may be due to the presence of phenolic constituents.
The most active extract found in the present screening was the MeOH extract of the flower of C. sinense (IC 50 , 5.1 mg/ml), which is used for the treatment of rheumatism and inflammatory diseases. To date, no chemical constituents have been reported from C. sinense, and thus we carried out further investigation to isolate and identify the active constituents. The MeOH extract of the flower of C. sinense was subjected to silica gel column chromatography to give six fractions. Further separation and purification of the active fractions with reversed-phase preparative TLC led to the isolation of caffeic acid 2) (1), luteolin 9) (2), eriodictyol 10) (3), and 1,5-di-O-caffeoylquinic acid 11) (4) (Fig. 1) . These compounds were examined for their XO inhibitory activity (Fig.  2) . Among them, luteolin (2) displayed more potent inhibitory activity (IC 50 , 1.3 mM) than the positive control allopurinol (IC 50 , 2.5 mM), while the IC 50 values of 1 and 4 were 85.3 mM and 64.4 mM, respectively. The increase in XO inhibitory activity of 2 compared with 3 (IC 50 , 43.8 mM) suggests the importance of the C 2 -C 3 double bond in flavonoids for the activity.
In order to determine the inhibition mode of 2, further kinetic studies were carried out. Lineweaver-Burk plots indicated 2 to be a competitive inhibitor, the same as allopurinol, with respect to the substrate, xanthine. The inhibition constant (K i ) of 2 was 0.92 mM, which was less than that of allopurinol (1.88 mM). Further HPLC analysis of the crude extract of C. sinense suggested the most active constituent 2 to be the major constituent (106 mg/mg of extract). Thus, the traditional use of C. sinense for the treatment of rheumatism and inflammatory deseases in Vietnam might be attributable to the XO inhibitory activity of flavonoid constituents such as 2.
In conclusion, we have carried out a systematic investigation of Vietnamese medicinal plants for XO inhibitory activity. The results indicate a number of medicinal plants that may be useful for the treatment of hyperuricemia and gout, and provide the basis for further investigation on these medicinal plant species to isolate active constituents and drug development. 
